Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.571%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: DP Poland sales improve; Braveheart swings to profit

Fri, 18th Jun 2021 13:23

(Alliance News) - The following is a round-up of updates by London-listed companies issued on Friday and not separately reported by Alliance News:

----------

DP Poland PLC - franchise in Poland for Domino's Pizza - Revenue increased by 7% to GBP15.0 million in 2020, with system sales up 5% year-on-year to GBP17.4 million. Like-for-like growth in system sales also was 5%. DP Poland says pretax loss widened to GBP5.8 million, primarily as a result of a significant increase in non-cash and non-recurring items, which totalled GBP2.3 million versus just GBP200,000 in 2019. The company says it had 69 stores at the end of 2020, with no new stores opened during the year. BP Poland notes that Covid-19 had no impact on its operations, as food delivery was not restricted in Poland and the delivery channel experienced "significant" growth. Going forward, the company says in the five months to May 31 its delivery sales increased 14% compared to the prior year and 28% compared to the same period of 2019. Takeaway sales also continue to perform strongly, up 6% year-on-year. System sales for the first five months of 2021 are flat year-on-year and down 5% when compared to 2019.

----------

Braveheart Investment Group PLC - Barnsley, England-based investment firm - Continues the review of its cost base and to reduce central costs. Revenue from the company's operations comprises investment management fees, with total revenue for the financial year to March 31 being GBP60,000, unchanged year-on-year. Revenue derived from strategic subsidiary undertakings has decreased to GBP205,000 from GBP386,000. Despite that, the company swings to pretax profit of GBP14.2 million from GBP575,000 loss the year before, as it had secured a GBP7.7 million profit on disposal of investments and GBP8.9 million profit on sale of subsidiary. No such profits were recorded the year prior.

----------

Montanaro European Smaller Cos Trust PLC - Lancing, England-based investment company - Reports net asset value per share as at March 31 of 1,589.0 pence, up from 956.9p the year prior. The company's share price at the end of its most recent financial year stood at 1,610.0p, representing a 1.3% premium to NAV. The trust declares a dividend of 9.25p, unchanged year-on-year. "It is notable that a large number of companies in the portfolio are today worth many times their original cost. We believe this demonstrates that the long term success the company has enjoyed is primarily due to good stock picking rather than shorter term style or economic cycles," says Chair Richard Curling.

----------

B90 Holdings PLC - Isle of Man-based online sportsbook and casino operator - Reports narrowed pretax loss in 2020 to EUR2.4 million from EUR4.4 million the year before, as total administrative expenses reduce to EUR3.1 million from EUR5.4 million year-on-year. Revenue, however, was lower, at EUR813,011 in 2020 versus EUR1.1 million in 2019. "The operational results were highly impacted as a result of the global Covid-19 pandemic, which caused a cancellation of the vast majority of sporting events globally from mid-March 2020," says Executive Chair Paul Duffen.

----------

Gresham House Renewable Energy VCT 1 PLC - investment firm - Reports NAV per ordinary share of 92.5p as at March 31 compared to 105.2p posted the year before and 106.7p reported at the end of September 2020. The company says overall performance in the six months to the end of March has been below expectations due to lower than forecast irradiation and legacy technical issues with the older ground-mounted solar assets. As at March 31, the venture capital trust held a portfolio of 16 investments, which were valued at GPB28.0 million.

----------

Gresham House Renewable Energy VCT 2 PLC - investment firm - Reports NAV per share as at March 31 of 91.6p, down from 104.1p a year prior and down from 105.5p as at the end of September 2020. The company says the overall value of its portfolio has fallen by 7.5% during the six months to the end of March, mainly as a result of changes in taxation that are scheduled to be introduced from 2023. As at March 31, the VCT held a portfolio of 16 investments, which were valued at GBP28.3 million.

----------

Utilico Emerging Markets Trust PLC - Epsom, England-based infrastructure investor - Reports NAV per share as at March 31 of 228.54p, up 26% year-on-year. Dividends per share for the financial year to March 31 total 7.775p, an increase of 2.6% on the year earlier. The company delivers a NAV total return of 30% for the year, outperforming the MSCI Emerging Markets Utilities Index which was only up by 17% during the twelve months. "Coupled with strong government and central bank support the board does not today see a significant risk from Covid-19 outside of market volatility in valuations," says Chair John Rennocks.

----------

Challenger Energy Group PLC - Caribbean and Atlantic focused oil and gas company - reports progress on the Saffron-2 appraisal well, targeting the upper, middle and lower cruse reservoirs with an expectation of production rates in the range of 200 - 300 barrels of oil per day. Initial third-party petrophysical analysis of logs from the secondary reservoir targets of the upper and middle cruse sections of the well indicate 165 feet of net-oil bearing reservoir sands, it says. Challenger Energy says drilling continues towards the primary lower cruse reservoir targets, with the well currently drilling at 3,850 feet against a target depth of 4,557 feet. The well remains on-track for completion around Wednesday next week.

----------

Zinnwald Lithium PLC - High Wycombe, England-based mineral exploration and development company - Says its 50%-owned subsidiary Deutsche Lithium GmbH has been granted a five-year exploration licence covering 225 hectares in the Erzgebirge or Ore Mountains region of Saxony, Germany. The Sadisdorf licence has the potential to provide additional resource upside to the company's Zinnwald lithium project.

----------

Zephyr Energy PLC - Newbury, England-based exploration & production company - Says due to commence a drilling programme on the Paradox project in US state of Utah in July. The planned appraisal well, the state 16-2LN-CC, will target the company's first production on the Paradox project.

----------

Angle PLC - Guildford, England-based liquid biopsy company - Reports results of a new study, by team of professors led by Evi Lianidou, undertaken in non-small cell lung cancer, which demonstrates the benefit of analysing circulating tumour cells, in addition to circulating tumour DNA, to inform treatment decisions. The aim of the study was to detect epithelial growth factor receptor mutations in circulating tumour DNA and matched circulating tumour cells from a single blood sample. The study used the Parsortix system to harvest circulating tumour cells in blood samples from 48 metastatic non-small cell lung cancer patients, with known epithelial growth factor receptor mutations, before treatment with a targeted therapy and again at disease progression. "Critically, this study supports the view that circulating tumour cells, rather than circulating tumour DNA, are key to gaining an insight into the future development of a patient's cancer," says Angle Founder & Chief Executive Andrew Newland.

----------

Yourgene Health PLC - Manchester, England-based diagnostic products developer - Secures contract to supply its Elucigene DPYD testing kits to NHS Wales. The UK contract award is for two years and is estimated to be worth GBP232,000.

----------

Sportech PLC - London-based betting technology company - Confirms the completion of three transactions: the sale of the global Tote business to BetMakers Technology, the sale of Bump 50:50 to Canadian Banknote, and the sale of a freehold property in New Haven, Connecticut. The net cash from all of these three transactions totals GBP36.1 million. Sportech says it intends to return the majority of proceeds to its shareholders when opportune to do so.

----------

Victoria Oil & Gas PLC - energy supplier in Africa - Says its subsidiary Gaz du Cameroun SA has agreed with Meridian Capital HK Ltd to raise a maximum of USD7.5 million through the issue of unsecured loan notes. The proceeds will be utilised for general working capital purposes, including long lead Items for the proposed well on the Matanda licence, offshore Cameroon.

----------

Gulf Keystone Petroleum Ltd - Bermuda-based oil & gas exploration and production company - Says it will consult with its shareholders after resolutions 2 and 6 were passed at the annual general meeting on Friday, but did not attain the support of 80% of shareholders who voted. The resolutions relate to re-apointment of Jaap Huijskes as director of the company.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 Aug 2019 10:57

Angle Ovarian Cancer Testing Platform Study Enrols First Patients

(Alliance News) - Liquid biopsy firm Angle PLC said Thursday the first patients for its ovarian cancer test study have been enrolled ahead of anticipated completion early in 2020.The study

Read more
29 Aug 2019 09:12

Angle initiates main phase of ovarian cancer clinical study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the main phase of its 200-patient ovarian cancer clinical verification study has been initiated and the first patient has been enrolled.

Read more
22 Jul 2019 12:53

Angle's Parsortix Used For Analysis Of Circulating Tumor Cells

(Alliance News) - Angle PLC on Monday said one of its leading customers, the Disseminated Cancer Cell Network, has published new results of work done to develop a "robust, reliable and for of

Read more
25 Jun 2019 08:16

Angle looks to strengthen balance sheet and extend runway via placement

(Sharecast News) - Liquid biopsy company Angle will look to raise up £18m at 61.5p per ordinary share through finnCap and WG Partners in order to strengthen its balance sheet and enable the development of key products.

Read more
21 Jun 2019 15:26

Angle upbeat on recent cancer research results

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the University Medical Centre Hamburg-Eppendorf (UKE) cancer centre has published results of work demonstrating that its 'Parsortix' system can be used as a liquid biopsy to investigate programmed death-ligand 1 (PD-L1) status in non small cell lung cancer (NSCLC) patients.

Read more
21 Jun 2019 12:56

Angle's Parsortix Successfully Investigates Immunotherapy Target

(Alliance News) - Angle PLC on Friday said its Parsortix system has been successfully used as a liquid biopsy to investigate an immunotherapy target in lung cancer.Shares in Angle were up a

Read more
5 Jun 2019 13:04

Angle's Parsortix And HyCEAD Ziplex Systems Identify Cancer In Study

LONDON (Alliance News) - Angle PLC on Wednesday announced positive results from a study evaluating the ability of its Parsortix and HyCEAD Ziplex platforms to test for ovarian cancer.The to

Read more
31 May 2019 09:53

Angle reveals positive results from latest Parsortix study

(Sharecast News) - Liquid biopsy company Angle announced positive results from its 'Parsortix' FDA clinical study for metastatic breast cancer on Friday.

Read more
26 Apr 2019 12:48

Angle's Parsortix system used in more groundbreaking research

(Sharecast News) - Liquid biopsy company Angle announced on Friday that its 'Parsortix' system has been utilised in further groundbreaking new cancer research, demonstrating the role of myeloid-derived suppressor cells (MDSCs) as part of large circulating tumor cell (CTC) clusters, which are 50x more likely to generate metastasis than single CTCs, for the first time.

Read more
26 Apr 2019 12:29

Angle's Parsortix System Used In Further "Groundbreaking" Research

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said its Parsortix system has been used in "groundbreaking" cancer research.The research showed the first the time

Read more
18 Apr 2019 11:35

US Cancer Centre Uses Angle's Parsortix System For Assessments

LONDON (Alliance News) - Angle PLC on Thursday said its ParsortixTM system was used by the University of Texas MD Anderson Cancer Center to develop a new technique for assessing the metastatic of

Read more
12 Apr 2019 15:25

Angle's Parsortix to be used in new Greece study

(Sharecast News) - Liquid biopsy company Angle announced on Friday that a leading customer has established a multi-centre study to investigate biomarkers on circulating tumor cells (CTCs), using its 'Parsortix' system, which could give advance warning of relapse in non small cell lung cancer (NSCLC).

Read more
12 Apr 2019 11:59

University Of Athens Cancer Study To Use Angle's Parsortix System

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said a "leading" customer has set up a multi-centre study using its Parsortix system.The study is being carried out

Read more
7 Mar 2019 13:09

Angle Enrols All 400 Patients In US Breast Cancer Study For Parsortix

LONDON (Alliance News) - Angle PLC on Thursday said it has completed enrolment for a US study of its Parsortix biopsy technology in metastatic breast cancer.All of the 400 subjects required

Read more
7 Mar 2019 09:35

Angle completes enrolment in Parsortix breast cancer study

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that enrolment for its 'Parsortix' FDA clinical study for metastatic breast cancer was now complete.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.